NCT01380496View on ClinicalTrials.gov

Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

November 30, 1999

Study Completion Date

November 30, 1999

Conditions
To Determine Bioequivalence Under Fed Conditions
Interventions
DRUG

doxycycline monohydrate

tablet, 100 mg, single, oral dose

DRUG

doxycycline monohydrate

Capsule, 100 mg, single, oral dose

DRUG

doxycycline monohydrate

Capsule, 100 mg, single, oral dose

Trial Locations (1)

Unknown

Anapharm Inc., Sainte-Foy

Sponsors

Collaborators (1)

Anapharm
All Listed Sponsors
collaborator

Anapharm

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY

NCT01380496 - Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter